💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ChemoCentryx, Inc. (CCXI)
« Back to company indexCCXI Chatter Timeline
Stock Ticker for CCXI
Most Active Tweeters for CCXI
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @nociFTW | 4 |
| @Allstocknews | 3 |
| @kevinjaybe | 2 |
| @semodough | 2 |
Recent Tweets for CCXI
 |
@QuantData We have identified an unusual $CCXI block that expires on May 21, 2021 with a strike price of $30.00. 5,000 PUT co… https://t.co/VByRlkNmKt April 19th 2021, 7:04pm |
 |
@Tickeron $CCXI in -1.69% Downtrend, falling for three consecutive days on April 16, 2021. View odds for this and other indic… https://t.co/fsELVQR1wd April 18th 2021, 3:04am |
|
@Tickeron $CCXI in -3.23% Downtrend, declining for three consecutive days on April 7, 2021. View odds for this and other indi… https://t.co/v2lEBDSzU6 April 17th 2021, 9:04am |
 |
@haodongvli $CCXI: looking forward to FDA panel meeting soon! Great R&D day! April 16th 2021, 6:04pm |
 |
@andrewkwil @nociFTW $CCXI Mgmt did a great job with the 4/14 presentation. I got thru most yesterday. Here they highlight the… https://t.co/D3LtlvxCzB April 16th 2021, 10:04am |
 |
@nociFTW $ccxi CCX559, oral small molecule pd-L1 inhibitor enters phase 1 next couple of months https://t.co/dFWyAp7ATq April 16th 2021, 9:04am |
|
@nociFTW $CCXI Teeling market research from chemocentryx. Dont think market really gets that "cortisone sparing" is a thing… https://t.co/8aHLqgmZhO April 16th 2021, 8:04am |
|
@Tickeron $CCXI in -3.23% Downtrend, sliding for three consecutive days on April 7, 2021. View odds for this and other indica… https://t.co/p2YOUg8K2T April 15th 2021, 11:04am |
 |
@DuarteSatirico RT @nociFTW: Very much enjoyed $ccxi R&D day. Starting phase 1 trials with oral PD-L1 antagonist in the next couple of month. Planning to s… April 14th 2021, 8:04pm |
 |
@semodough @nociFTW Link for $CCXI webcast today but not seen slide deck yet https://t.co/vihsrMZk12 April 14th 2021, 8:04pm |
|
@nociFTW Very much enjoyed $ccxi R&D day. Starting phase 1 trials with oral PD-L1 antagonist in the next couple of month. Pl… https://t.co/lLjI2aAxJu April 14th 2021, 7:04pm |
 |
@savage_swings $CCXI #Earnings 5/10 Looks like a double bottom ?? Presenting a good entry. Raymond James “Strong Buy” with a 120 P… https://t.co/obtGz0HlnJ April 14th 2021, 2:04am |
 |
@YouCanFoolMost RT @Tickeron: $CCXI in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/IJriREuYsz #ChemoC… April 12th 2021, 10:04pm |
|
@Tickeron $CCXI in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/qX83KF7zq0 April 12th 2021, 10:04pm |
 |
@hazzopardi RT @malteseinvest: $CCXI Bought 54.30 & 49.70 SL 44.30 - Target 77.00, 88.35 Needs to hold above 46.15 A close above 55.47 then 59.57… April 12th 2021, 8:04pm |
 |
@hermeneuticlens New position $CCXI (47) short put @ 30 exp May 21 for 1.9, 6.3% return on risk. Clearly mispriced, unless the marke… https://t.co/vrkxGBS8nn April 12th 2021, 7:04pm |
 |
@sbwcws ChemoCentryx to host virtual research and development day $CCXI April 12th 2021, 6:04pm |
 |
@funnystemcells @DeepSouthDoctor Being Biotech Long Is Harder Than HHHypergrowth Techs !! @haodongvli ‘s perspective helps. Added $CCXI today. April 12th 2021, 5:04pm |
 |
@malteseinvest $CCXI Bought 54.30 & 49.70 SL 44.30 - Target 77.00, 88.35 Needs to hold above 46.15 A close above 55.47 then 5… https://t.co/JwKkwRbGcF April 12th 2021, 2:04pm |
|
@Tickeron $CCXI in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/t5awvjslb5 April 11th 2021, 11:04am |
 |
@nolastevedore @semodough Very excited for $CCXI. Could fully validate chemokine tech, offer a non-steroidal option in the targete… https://t.co/EvIw6eOUBE April 10th 2021, 10:04pm |
 |
@MarcJacksonLA $CCXI ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association… https://t.co/5eIvAnqB2b April 10th 2021, 2:04pm |
|
@semodough $CCXI Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association for Cancer Res… https://t.co/J2omPFdhlE April 9th 2021, 12:04pm |
 |
@FlashAlert_me $CCXI [15s. delayed]: Issued Press Release on April 09, 08:30:00: ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Feat… https://t.co/wuMSMvqEZO April 9th 2021, 12:04pm |
 |
@Allstocknews $CCXI ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Assoc From our Stock News Alerts App April 9th 2021, 12:04pm |
 |
@kevinjaybe $CCXI Chemocentryx’S Oral Pd-L1 Inhibitor, Ccx559, Featured In Poster Presentation At The 2021 American Association… https://t.co/g5uuIIddvf April 9th 2021, 12:04pm |
 |
@TeamofStockTra RT @AkramMSiddique: $CCXI - ChemoCentryx Says Co's Oral PD-L1 Inhibitor CCX559, Featured In Poster Presentation At 2021 American Associatio… April 9th 2021, 12:04pm |
 |
@AkramMSiddique $CCXI - ChemoCentryx Says Co's Oral PD-L1 Inhibitor CCX559, Featured In Poster Presentation At 2021 American Associ… https://t.co/9ZHzxOf0Hb April 9th 2021, 12:04pm |
 |
@stock_titan $CCXI ChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in Poster Presentation at the 2021 American Association… https://t.co/92YuyfRakm April 9th 2021, 12:04pm |
 |
@botpicks Should I Go Long or Short $CCXI ? April 9th 2021, 6:04am |
|
@Tickeron $CCXI in -3.23% Downtrend, sliding for three consecutive days on April 7, 2021. View odds for this and other indica… https://t.co/sUCScRMW7k April 8th 2021, 4:04pm |
 |
@Gambiste1 RT @nociFTW: $CCXI down 30% from peak. PDUFA for avacopan in June, very well capitalized. R&D day next week, will present new oral PD-1 inh… April 8th 2021, 9:04am |
|
@nociFTW $CCXI down 30% from peak. PDUFA for avacopan in June, very well capitalized. R&D day next week, will present new or… https://t.co/g7oPc2CUvQ April 8th 2021, 9:04am |
 |
@newsfilterio ChemoCentryx to Host Virtual R&D Day on April 14, 2021 $CCXI https://t.co/xznSkuPMam April 8th 2021, 4:04am |
|
@Allstocknews $CCXI New Form DEF 14A for ChemoCentryx, Inc. From our Stock News Alerts App April 7th 2021, 8:04pm |
|
@kevinjaybe $CCXI Chemocentryx To Host Virtual R&D Day On April 14, 2021 https://t.co/g9sHMgopT2 April 7th 2021, 12:04pm |
|
@Allstocknews $CCXI ChemoCentryx to Host Virtual R&D Day on April 14, 2021 From our Stock News Alerts App April 7th 2021, 12:04pm |
 |
@Beeken_health $CCXI - ChemoCentryx to Host Virtual R&D Day on April 14, 2021 https://t.co/rfR590AokE https://t.co/2H71g1TaSA April 7th 2021, 12:04pm |
 |
@bthefirsttoknow $CCXI: ChemoCentryx to Host Virtual R&D Day on April 14, 2021 https://t.co/AoyXjNFWKX April 7th 2021, 12:04pm |
|
@stock_titan $CCXI ChemoCentryx to Host Virtual R&D Day on April 14, 2021 https://t.co/8xyUynVv47 April 7th 2021, 12:04pm |
|
@Tickeron $CCXI in -3.2% Downtrend, declining for three consecutive days on April 5, 2021. View odds for this and other indic… https://t.co/7Yp2QZT1x1 April 7th 2021, 9:04am |
 |
@PSAzzopardi RT @malteseinvest: $CCXI Bought 54.30 & 49.70 SL 44.30 - Target 77.00, 88.35 Failed to reclaim the TL @ 54.02 & down again (Original… April 6th 2021, 3:04am |
 |
@DalhiMackle @matthewherper Every $CCXI investor....and there the drug met/exceeded its endpoints with benign safety and The FDA… https://t.co/8gfB0djomv April 5th 2021, 7:04pm |
|
@malteseinvest $CCXI Bought 54.30 & 49.70 SL 44.30 - Target 77.00, 88.35 Failed to reclaim the TL @ 54.02 & down again (Orig… https://t.co/l8RmXkFLbf April 5th 2021, 2:04pm |
|
@Tickeron $CCXI's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/IydWaUixHU April 4th 2021, 7:04am |
|
@Tickeron $CCXI's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/9InPXuYcyb April 3rd 2021, 11:04am |
 |
@Quick2smile @andrewkwil Just seeing this now......Alexion buying out Achillion and then kinda burying their assets Helped $CCXI… https://t.co/UC5c3B0Nkg March 31st 2021, 4:03pm |
 |
@InsiderAlerts4U $CCXI: New Insider Filing on ChemoCentryx, Inc.'s Director RITA JAIN: https://t.co/0tgdViBlyG March 31st 2021, 1:03am |
|
@Tickeron $CCXI enters a Downtrend as Momentum Indicator dropped below the 0 level on March 23, 2021. View odds for this and… https://t.co/JR5ePGQnyv March 31st 2021, 12:03am |
|
@Allstocknews $CCXI New Form 4 for ChemoCentryx, Inc. From our Stock News Alerts App March 31st 2021, 12:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
